Australian Clinical Labs Limited
ASX:ACL.AX
Overview | Financials
Company Name | Australian Clinical Labs Limited |
Symbol | ACL.AX |
Currency | AUD |
Price | 3.59 |
Market Cap | 718,218,139 |
Dividend Yield | 4.08% |
52-week-range | 2.14 - 3.855 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Melinda McGrath |
Website | https://www.clinicallabs.com.au |
An error occurred while fetching data.
About Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD